Arbutus Biopharma Corp. (ABUS)
5.20
-0.01
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price to Book Value : 3.972 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.972 |
| August 21, 2026 | 3.980 |
| August 20, 2026 | 3.644 |
| August 19, 2026 | 3.804 |
| August 18, 2026 | 3.697 |
| August 17, 2026 | 3.598 |
| August 14, 2026 | 3.567 |
| August 13, 2026 | 3.498 |
| August 12, 2026 | 3.506 |
| August 11, 2026 | 3.567 |
| August 10, 2026 | 3.506 |
| August 07, 2026 | 3.537 |
| August 06, 2026 | 3.468 |
| August 05, 2026 | 3.529 |
| August 04, 2026 | 3.376 |
| August 03, 2026 | 3.330 |
| July 31, 2026 | 3.315 |
| July 30, 2026 | 3.369 |
| July 29, 2026 | 3.277 |
| July 28, 2026 | 3.369 |
| July 27, 2026 | 3.369 |
| July 24, 2026 | 3.346 |
| July 23, 2026 | 3.414 |
| July 22, 2026 | 3.308 |
| July 21, 2026 | 3.453 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.369 |
| July 17, 2026 | 3.483 |
| July 16, 2026 | 3.621 |
| July 15, 2026 | 3.483 |
| July 14, 2026 | 3.521 |
| July 13, 2026 | 3.563 |
| July 10, 2026 | 3.666 |
| July 09, 2026 | 3.926 |
| July 08, 2026 | 3.987 |
| July 07, 2026 | 3.957 |
| July 06, 2026 | 3.796 |
| July 02, 2026 | 3.72 |
| July 01, 2026 | 3.613 |
| June 30, 2026 | 3.666 |
| June 29, 2026 | 3.543 |
| June 26, 2026 | 3.467 |
| June 25, 2026 | 3.338 |
| June 24, 2026 | 3.376 |
| June 23, 2026 | 3.368 |
| June 22, 2026 | 3.422 |
| June 18, 2026 | 3.444 |
| June 17, 2026 | 3.353 |
| June 16, 2026 | 3.323 |
| June 15, 2026 | 3.270 |
| June 12, 2026 | 3.225 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 8.197 |
| Insmed, Inc. | 35.73 |
| Pfizer Inc. | 1.871 |
| Gossamer Bio, Inc. | -- |
| Legend Biotech Corp. | 3.300 |
Price to Book Value Related Metrics
| PE Ratio | 6.638 |
| PS Ratio | 5.558 |
| Price | 5.20 |
| Earnings Yield | 15.07% |
| Market Cap | 1.028B |
| Operating PE Ratio | 6.851 |
| Normalized PE Ratio | 6.687 |